A detailed history of Baldrige Asset Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Baldrige Asset Management LLC holds 500 shares of ABT stock, worth $51,165. This represents 0.02% of its overall portfolio holdings.

Number of Shares
500
Previous 614 18.57%
Holding current value
$51,165
Previous $67,000 23.88%
% of portfolio
0.02%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

SELL
$96.86 - $114.01 $11,042 - $12,997
-114 Reduced 18.57%
500 $51,000
Q4 2022

Jan 13, 2023

BUY
$95.06 - $111.52 $21,673 - $25,426
228 Added 59.07%
614 $67,000
Q1 2022

Apr 26, 2022

SELL
$114.02 - $139.04 $9,577 - $11,679
-84 Reduced 17.87%
386 $46,000
Q4 2021

Jan 27, 2022

SELL
$115.53 - $141.46 $4,621 - $5,658
-40 Reduced 7.84%
470 $66,000
Q3 2021

Oct 22, 2021

SELL
$116.66 - $129.06 $4,666 - $5,162
-40 Reduced 7.27%
510 $60,000
Q2 2021

Aug 03, 2021

BUY
$105.79 - $124.53 $58,184 - $68,491
550 New
550 $64,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Baldrige Asset Management LLC Portfolio

Follow Baldrige Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldrige Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldrige Asset Management LLC with notifications on news.